{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:26:02Z","timestamp":1790882762187,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T00:00:00Z","timestamp":1656028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T00:00:00Z","timestamp":1656028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oral Maxillofac Surg"],"DOI":"10.1007\/s10006-022-01094-7","type":"journal-article","created":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T00:32:37Z","timestamp":1656030757000},"page":"507-512","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Efficacy of fibrin-rich platelets and leukocytes (L-PRF) in tissue repair in surgical oral procedures in patients using zoledronic acid\u2014case\u2013control study"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0417-9979","authenticated-orcid":false,"given":"Guilherme Klein","family":"Parise","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda Nazareth","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miri\u00e3 Lima","family":"Nogueira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurindo Moacir","family":"Sassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana Lucena","family":"Schussel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,24]]},"reference":[{"issue":"1","key":"1094_CR1","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41368-020-00093-2","volume":"12","author":"L He","year":"2020","unstructured":"He L, Sun X, Liu Z, Qiu Y, Niu Y (2020) Pathogenesis and multidisciplinary management of medication-related osteonecrosis of the jaw. Int J Oral Sci 12(1):30","journal-title":"Int J Oral Sci"},{"issue":"9","key":"1094_CR2","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","volume":"61","author":"RE Marx","year":"2003","unstructured":"Marx RE (2003) Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 61(9):1115\u20131117","journal-title":"J Oral Maxillofac Surg"},{"issue":"1","key":"1094_CR3","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jormas.2019.02.011","volume":"121","author":"Fernando de Almeida","year":"2020","unstructured":"de Almeida Fernando, Barros Mourao C, Calasans-Maia MD, Del Fabbro M, Le Drapper Vieira F, de Mello Coutinho, Machado R, Capella R et al (2020) The use of platelet-rich fibrin in the management of medication-related osteonecrosis of the jaw: a case series. J Stomatol Oral Maxillofac Surg. 121(1):84\u20139","journal-title":"J Stomatol Oral Maxillofac Surg."},{"issue":"10","key":"1094_CR4","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","volume":"72","author":"SL Ruggiero","year":"2014","unstructured":"Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B et al (2014) American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw\u20142014 update. J Oral Maxillofac Surg 72(10):1938\u20131956","journal-title":"J Oral Maxillofac Surg"},{"issue":"4","key":"1094_CR5","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1590\/1516-3180.2019.0352.r2.15052020","volume":"138","author":"AP Maciel","year":"2020","unstructured":"Maciel AP, Quispe RA, Martins LJO, Caldas RJ, Santos P (2020) Clinical profile of individuals with bisphosphonate-related osteonecrosis of the jaw: an integrative review. Sao Paulo Med J 138(4):326\u2013335","journal-title":"Sao Paulo Med J"},{"key":"1094_CR6","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1146\/annurev.pharmtox.38.1.375","volume":"38","author":"GA Rodan","year":"1998","unstructured":"Rodan GA (1998) Mechanisms of action of bisphosphonates. Annu Rev Pharmacol Toxicol San Diego 38:375\u2013388","journal-title":"Annu Rev Pharmacol Toxicol San Diego"},{"issue":"1","key":"1094_CR7","doi-asserted-by":"publisher","first-page":"8310","DOI":"10.1038\/s41598-019-43798-z","volume":"9","author":"D Steller","year":"2019","unstructured":"Steller D, Herbst N, Pries R, Juhl D, Hakim SG (2019) Positive impact of platelet-rich plasma and platelet-rich fibrin on viability, migration and proliferation of osteoblasts and fibroblasts treated with zoledronic acid. Sci Rep 9(1):8310","journal-title":"Sci Rep"},{"issue":"1","key":"1094_CR8","doi-asserted-by":"publisher","first-page":"3543","DOI":"10.5272\/jimab.2021271.3543","volume":"27","author":"M Hristamyan","year":"2021","unstructured":"Hristamyan M, Raycheva R, Pechalova P, Hristamyan V, Stoilova Y (2021) Risk factors in patients with bisphosphonate - associated osteonecrosis of the jaws. Journal of IMAB - Annual Proceeding (Scientific Papers) 27(1):3543\u20133548","journal-title":"Journal of IMAB - Annual Proceeding (Scientific Papers)"},{"key":"1094_CR9","doi-asserted-by":"crossref","unstructured":"De Cassia Tornier S, Macedo FJ, Sassi LM, Schussel JL. (2021) Quality of life in cancer patients with or without medication-related osteonecrosis of the jaw. Supportive Care in Cancer, [s. l.], n. 0123456789.","DOI":"10.1007\/s00520-021-06275-w"},{"issue":"25","key":"1094_CR10","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1200\/JCO.19.01186","volume":"37","author":"N Yarom","year":"2019","unstructured":"Yarom N, Shapiro CL, Peterson DE, Van Poznak CH, Bohlke K, Ruggiero SL et al (2019) Medication-related osteonecrosis of the jaw: MASCC\/ISOO\/ASCO clinical practice guideline. J Clin Oncol 37(25):2270\u20132290","journal-title":"J Clin Oncol"},{"key":"1094_CR11","doi-asserted-by":"crossref","unstructured":"Yuce MO, Adali E, Isik G. (2021) The effect of concentrated growth factor (CGF) in the surgical treatment of medication-related osteonecrosis of the jaw (MRONJ) in osteoporosis patients: a randomized controlled study. Clin Oral Investig.","DOI":"10.1007\/s00784-020-03766-8"},{"issue":"11","key":"1094_CR12","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.oraloncology.2014.08.016","volume":"50","author":"K Rupel","year":"2014","unstructured":"Rupel K, Ottaviani G, Gobbo M, Contardo L, Tirelli G, Vescovi P et al (2014) A systematic review of therapeutical approaches in bisphosphonates-related osteonecrosis of the jaw (BRONJ). Oral Oncol 50(11):1049\u20131057","journal-title":"Oral Oncol"},{"issue":"3","key":"1094_CR13","first-page":"811","volume":"31","author":"F Inchingolo","year":"2017","unstructured":"Inchingolo F, Cantore S, Dipalma G, Georgakopoulos I, Almasri M, Gheno E, Motta A, Marrelli M, Farronato D, Ballini A, Marzullo A (2017) Platelet rich fibrin in the management of medication-related osteonecrosis of the jaw: a clinical and histopathological evaluation. J Biol Regul Homeost Agents. 31(3):811\u2013816","journal-title":"J Biol Regul Homeost Agents."},{"issue":"5","key":"1094_CR14","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.joms.2019.12.008","volume":"78","author":"S Szentpeteri","year":"2020","unstructured":"Szentpeteri S, Schmidt L, Restar L, Csaki G, Szabo G, Vaszilko M (2020) The effect of platelet-rich fibrin membrane in surgical therapy of medication-related osteonecrosis of the jaw. J Oral Maxillofac Surg 78(5):738\u2013748","journal-title":"J Oral Maxillofac Surg"},{"issue":"2","key":"1094_CR15","first-page":"1","volume":"57","author":"DF Nica","year":"2021","unstructured":"Nica DF, Rivi\u0219 M, Roi CI, Todea CD, Duma VF, Sinescu C (2021) Complementarity of photo-biomodulation, surgical treatment, and antibiotherapy for medication-related osteonecrosis of the jaws (MRONJ). Med 57(2):1\u201314","journal-title":"Med"},{"issue":"March","key":"1094_CR16","doi-asserted-by":"publisher","first-page":"100076","DOI":"10.1016\/j.adoms.2021.100076","volume":"2","author":"AI Bracher","year":"2021","unstructured":"Bracher AI, Vig N, Burkhard J-P, Schaller B, Schlittler F (2021) The application of platelet rich fibrin in patients presenting with osteonecrosis of the jaw: a systematic literature review. Adv Oral Maxillofac Surg 2(March):100076","journal-title":"Adv Oral Maxillofac Surg"},{"issue":"9","key":"1094_CR17","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/j.bjoms.2014.07.256","volume":"52","author":"JW Kim","year":"2014","unstructured":"Kim JW, Kim SJ, Kim MR (2014) Leucocyte-rich and platelet-rich fibrin for the treatment of bisphosphonate-related osteonecrosis of the jaw: a prospective feasibility study. Br J Oral Maxillofac Surg 52(9):854\u2013859","journal-title":"Br J Oral Maxillofac Surg"},{"issue":"9","key":"1094_CR18","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1016\/j.joms.2011.02.078","volume":"69","author":"MM Curi","year":"2011","unstructured":"Curi MM, Cossolin GSI, Koga DH, Zardetto C, Christianini S, Feher O et al (2011) Bisphosphonate-related osteonecrosis of the jaws - an initial case series report of treatment combining partial bone resection and autologous platelet-rich plasma. J Oral Maxillofac Surg 69(9):2465\u20132472","journal-title":"J Oral Maxillofac Surg"},{"issue":"6","key":"1094_CR19","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1016\/j.joms.2016.12.005","volume":"75","author":"JH Park","year":"2017","unstructured":"Park JH, Kim JW, Kim SJ (2017) Does the addition of bone morphogenetic protein 2 to platelet-rich fibrin improve healing after treatment for medication-related osteonecrosis of the jaw? J Oral Maxillofac Surg 75(6):1176\u20131184","journal-title":"J Oral Maxillofac Surg"},{"issue":"1","key":"1094_CR20","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.joms.2017.06.004","volume":"76","author":"G Maluf","year":"2018","unstructured":"Maluf G, Caldas RJ, Silva Santos PS (2018) Use of leukocyte- and platelet-rich fibrin in the treatment of medication-related osteonecrosis of the jaws. J Oral Maxillofac Surg 76(1):88\u201396","journal-title":"J Oral Maxillofac Surg"},{"issue":"1","key":"1094_CR21","first-page":"5","volume":"3","author":"E Michael","year":"2019","unstructured":"Michael E, Pooja G, Sneha S (2019) Mylohyoid flap and platelet rich fibrin in the treatment of medication related osteonecrosis of the jaws. Res Reports Oral Maxillofac Surg 3(1):5\u20138","journal-title":"Res Reports Oral Maxillofac Surg"},{"key":"1094_CR22","doi-asserted-by":"crossref","unstructured":"Bennardo F, Buffone C, Muraca D, Antonelli A, Giudice A. (2020) Medication-related osteonecrosis of the jaw with spontaneous hemimaxilla exfoliation: report of a case in metastatic renal cancer patient under multidrug therapy. Case Rep Med. 2020.","DOI":"10.1155\/2020\/8093293"},{"issue":"7","key":"1094_CR23","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1007\/s00784-016-2004-z","volume":"21","author":"T Asaka","year":"2017","unstructured":"Asaka T, Ohga N, Yamazaki Y, Sato J, Satoh C, Kitagawa Y (2017) Platelet-rich fibrin may reduce the risk of delayed recovery in tooth-extracted patients undergoing oral bisphosphonate therapy: a trial study. Clin Oral Investig 21(7):2165\u20132172","journal-title":"Clin Oral Investig"},{"issue":"3","key":"1094_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/pharmaceutics13030354","volume":"13","author":"F Michalak","year":"2021","unstructured":"Michalak F, Hnitecka S, Dominiak M, Grzech-Le\u015bniak K (2021) Schemes for drug-induced treatment of osteonecrosis of jaws with particular emphasis on the influence of vitamin d on therapeutic effects. Pharmaceutics 13(3):1\u201313","journal-title":"Pharmaceutics"},{"key":"1094_CR25","doi-asserted-by":"crossref","unstructured":"Yanaguizawa WH, Velasco SK, Petersen RL, Alves FDA, Cavalcanti MGP. (2020) Imaging modalities in medication-related osteonecrosis of the jaw. Clin Lab Res Dent. 1\u20137.","DOI":"10.11606\/issn.2357-8041.clrd.2020.164723"},{"key":"1094_CR26","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3390\/antiox10050680","volume":"10","author":"SW On","year":"2021","unstructured":"On SW, Cho SW, Byun SH, Yang BE (2021) Various therapeutic methods for the treatment of medication-related osteonecrosis of the jaw (MRONJ) and their limitations: a narrative review on new molecular and cellular therapeutic approaches. Antioxidants. 10:5","journal-title":"Antioxidants."},{"key":"1094_CR27","doi-asserted-by":"crossref","unstructured":"\u015eahin O, Akan E, Tatar B, Ekmekcio\u011flu C, \u00dcnal N, Odaba\u015f\u0131 O. (2021) Combined approach to treatment of advanced stages of medication-related osteonecrosis of the jaw patients. Braz J Otorhinolaryngol. (xx).","DOI":"10.1016\/j.bjorl.2021.04.004"},{"key":"1094_CR28","doi-asserted-by":"crossref","unstructured":"Law B, Soh HY, Nabil S, Rajandram RK, Nazimi AJ, Ramli R. Autologous platelet-rich fibrin (PRF) as an adjunct in the management of osteoradionecrosis and medication-related osteonecrosis of jaws. case series in a single centre. Appl Sci. 2021;11(8).","DOI":"10.3390\/app11083365"},{"key":"1094_CR29","doi-asserted-by":"crossref","unstructured":"Miranda M, Gianfreda F, Raffone C, Antonacci D, Pistilli V, Bollero P. (2021) The role of platelet-rich fibrin (PRF) in the prevention of medication-related osteonecrosis of the jaw (MRONJ). Biomed Res Int. 2021.","DOI":"10.1155\/2021\/4948139"},{"issue":"3","key":"1094_CR30","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.jcms.2020.01.014","volume":"48","author":"L Fortunato","year":"2020","unstructured":"Fortunato L, Bennardo F, Buffone C, Giudice A (2020) Is the application of platelet concentrates effective in the prevention and treatment of medication-related osteonecrosis of the jaw? A systematic review J Cranio-Maxillofacial Surg 48(3):268\u2013285","journal-title":"A systematic review J Cranio-Maxillofacial Surg"},{"issue":"1","key":"1094_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41368-020-00093-2","volume":"12","author":"L He","year":"2020","unstructured":"He L, Sun X, Liu Z, Qiu Y, Niu Y (2020) Pathogenesis and multidisciplinary management of medication-related osteonecrosis of the jaw. Int J Oral Sci 12(1):1\u201311","journal-title":"Int J Oral Sci"},{"issue":"1","key":"1094_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41368-020-00099-w","volume":"12","author":"M Feng","year":"2020","unstructured":"Feng M, Wang Y, Zhang P, Zhao Q, Yu S, Shen K et al (2020) Antibacterial effects of platelet-rich fibrin produced by horizontal centrifugation. Int J Oral Sci 12(1):1\u20138","journal-title":"Int J Oral Sci"}],"container-title":["Oral and Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10006-022-01094-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10006-022-01094-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10006-022-01094-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T13:06:27Z","timestamp":1744203987000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10006-022-01094-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,24]]},"references-count":32,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,9]]}},"alternative-id":["1094"],"URL":"https:\/\/doi.org\/10.1007\/s10006-022-01094-7","relation":{},"ISSN":["1865-1569"],"issn-type":[{"value":"1865-1569","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,24]]},"assertion":[{"value":"13 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research was submitted and approved by the Ethics Committee in Research of the Erasto Gaertner Hospital and registered in the National System of Ethics in Research\u2014SISNEP under the number 27354919.8.0000.0098.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All participants have consented to the submission of the case report to the journal.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}